OECD TG 406
OECD TG 406 is the standard for ‘skin sensitisation’, which is included in Section 4 (Health Effects) of the OECD Test Guidelines for the testing of chemicals. It was first adopted in 1981 and updated in 1992. The test is an in vivo test designed to assess a substance’s potential to induce a delayed hypersensitivity reaction (Type IV) following repeated skin contact, i.e. its potential to cause contact allergy.
Note on regulatory status: In current regulatory practice, OECD TG 406 has largely been superseded by the OECD TG 442 series (TG 442A, 442B, 442C, 442D, 442E and TG 429 LLNA). Nevertheless, TG 406 continues to be used as a reference in some regulatory frameworks, namely when evaluating existing dossiers, in cases where the LLNA test is not suitable (e.g. for metals or certain substances that produce false-negative or false-positive results), as well as when interpreting historical data sets.
The test comprises two basic methods:
Guinea Pig Maximisation Test (GPMT – Magnusson-Kligman):
- This is an adjuvant method; Freund’s Complete Adjuvant (FCA) is used in this process
- Intradermal induction: The test substance is injected under the skin together with FCA (usually on day 0)
- Topical induction: The test substance is applied topically to the same site (usually on day 7)
- Challenge (re-exposure): After a rest period of approximately 14 days (usually on days 21–28), the test substance is applied topically to a new area of skin
- Monitoring takes place after 24, 48 and 72 hours
- Due to the use of an adjuvant, this method exhibits greater sensitivity; it is advantageous for the detection of weak sensitising agents
Buehler test (occlusive patch test):
- This is an adjuvant-free method; only topical application is used
- Induction: The test substance is usually applied under an occlusive plaster for 6 hours; this procedure is generally repeated once a week for three weeks
- Challenge: Around 14 days after the last induction, the substance is applied to a new area using an occlusive plaster
- Monitoring takes place after 24, 48 and 72 hours
- As no adjuvant is used, this method is less sensitive; it is suitable for the detection of strong and moderately strong sensitising agents
In both methods, assessment is carried out using the Magnusson-Kligman scale:
- Erythema: 0 (none) – 1 (mild, patchy) – 2 (moderate, continuous) – 3 (severe, oedematous/necrotic)
- Oedema: 0 (none) – 1 (mild) – 2 (moderate) – 3 (severe)
The key parameters reported in the study are:
- Method used (GPMT or Buehler) and justification
- Induction and Challenge--doses, -concentrations and -carriers
- Erythema and oedema scores following the challenge (each animal, each observation time point)
- Number of animals that responded and their percentage
- Positive control results and validity criteria
- GHS/CLP skin sensitisation category (Category 1, 1A, 1B or not classified) and justification
- Animal species used, sex, age, equipment and environmental conditions
- Data on measurement uncertainty and repeatability
Why is it carried out?
OECD TG 406 is being carried out for the following scientific and regulatory purposes:
- Determination of contact allergy potential: Assessment of a substance’s potential to trigger delayed hypersensitivity following repeated skin contact
- GHS/CLP classification: Determination of the skin sensitisation category of the substance (Category 1, 1A, 1B) and specification of the labelling requirements (H317)
- Support for regulatory documentation: Use in safety assessments of chemicals, pesticides, biocidal products, cosmetics, medicinal products and medical devices
- Product safety and labelling: establishing warning notices and safety measures to protect consumers and workers
- Analysis of historical data: Evaluation of existing TG-406 studies within the current regulatory context and comparison with data from the TG-442 series
- Cases in which alternative methods are unsuitable: the use of guinea pig tests for substances for which the LLNA is unsuitable or produces misleading results (e.g. metals, certain surfactants)
- Evidence-based approach: a contribution to the holistic assessment of the substance in conjunction with other toxicological, physicochemical and exposure data
- Quality control: Monitoring the consistency of the sensitising potential of substances throughout the production processes
OECD TG 406 does not, in itself, provide any information on systemic toxicity, irritation or corrosivity; these effects must be assessed in separate tests (e.g. TG 402, TG 404, TG 405). The results should be interpreted in the context of the substance’s physicochemical properties, structural alerts and the exposure assessment.
As part of our nano-testing services, we carry out skin sensitisation studies in accordance with OECD TG 406, as well as the procedures set out in the OECD TG 442 series – which is the current equivalent of this standard – within the framework of our accredited laboratory infrastructure and our quality management system, applying scientific rigour.
Our range of services includes the following:
Selection and justification of the appropriate method (GPMT, Buehler or the TG 442 series) in accordance with the properties of the test substance, the available data and the regulatory requirements
Determination of the dose/concentration (determination of the irritation threshold) and design of the main study
Definition of the negative control, the vehicle control and suitable positive control groups; scientific justification regarding species, sex, age, vehicle and conditions of use; compliance with the requirements regarding ethical approval and animal welfare
For information on the selection of methods, dose determination, planning of positive controls, sample acceptance criteria, the test schedule and the reporting procedures for your skin sensitisation studies in accordance with OECD TG 406 and its current equivalent, the OECD TG 442 series, please contact Nano-Test.

